Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
GLP-1 medications work for everyone — but for women, several unique biological factors shape the experience and outcomes of semaglutide treatment. From PCOS and fertility to perimenopause and the menstrual cycle, here is the complete women’s guide to semaglutide.
Efficacy in Women
The STEP trials enrolled a majority female population and showed that women achieve broadly comparable percentage weight loss to men — averaging 14–16% at 2.4mg over 68 weeks. Some analyses suggest women may respond slightly better at lower doses due to differences in GLP-1 receptor density, but this has not been consistently replicated. For practical purposes, women should expect equivalent efficacy to men.
PCOS and Semaglutide
Polycystic ovary syndrome (PCOS) is fundamentally a condition of insulin resistance, hyperandrogenism, and ovulatory dysfunction — and semaglutide addresses all three indirectly. Improving insulin sensitivity reduces androgen overproduction from the ovaries, improving both hirsutism and acne. Regular ovulation often returns as insulin resistance resolves and weight decreases. Multiple case series and small trials show semaglutide producing improvements in PCOS hormone panels and menstrual regularity. For women with PCOS, semaglutide may be particularly beneficial beyond weight loss alone.
Perimenopause and Menopause
The hormonal shifts of perimenopause — declining oestrogen and progesterone — promote visceral fat accumulation, insulin resistance, and metabolic syndrome. Semaglutide specifically targets visceral adiposity, making it especially well-suited for perimenopausal and postmenopausal women. Women in this life stage frequently report that semaglutide achieves results that previous diet and exercise attempts could not, because it addresses the biological resistance to fat loss that hormonal changes create.
Fertility Considerations
Semaglutide must be discontinued at least 2 months before attempting conception (the drug has a long half-life). It is contraindicated in pregnancy due to absence of safety data and theoretical concerns from animal studies. However, improving metabolic health before conception — then stopping in time — is a clinically discussed approach, especially for women with PCOS where improving ovulation regularity and insulin sensitivity before pregnancy has clear benefits. Discuss timing carefully with your OB/GYN and prescribing physician.
Bone Health
Significant weight loss from any cause — including semaglutide — can reduce bone mineral density, particularly in postmenopausal women who are already at higher osteoporosis risk. Ensure adequate calcium (1,200mg daily) and vitamin D (1,000–2,000 IU daily) supplementation. Weight-bearing exercise and resistance training are protective for bone density and should be prioritised.
Frequently Asked Questions
Q: Does Ozempic work differently for women?
A: Women generally respond very similarly to men in terms of overall weight loss percentage on semaglutide — the STEP trials showed comparable efficacy across sexes. However, hormonal factors (menstrual cycle, perimenopause, PCOS) interact with GLP-1 treatment in clinically meaningful ways. Women with PCOS often see disproportionate benefits including improved menstrual regularity and androgen levels. Perimenopausal women benefit from semaglutide’s ability to target visceral fat accumulation that accelerates during hormonal transition.
Q: Can women take Ozempic while trying to get pregnant?
A: Semaglutide should be discontinued at least 2 months before attempting to conceive. It is contraindicated during pregnancy and breastfeeding. However, improving metabolic health and insulin sensitivity with semaglutide before conception — then discontinuing it before trying to conceive — is a reasonable clinical approach discussed with your physician. Women with PCOS specifically may see improved fertility markers with semaglutide treatment.
Q: Does Ozempic affect your menstrual cycle?
A: Some women report changes to their menstrual cycle on semaglutide, particularly in the early months. Changes are typically indirect — significant weight loss and caloric restriction can temporarily disrupt hypothalamic-pituitary signalling, affecting cycle regularity. Most women’s cycles normalise as weight stabilises. Women with PCOS often see improved cycle regularity as insulin resistance improves. Report any persistent cycle irregularity to your physician.
📖 Further Reading
Start Semaglutide — Physician Supervised
Proper assessment and monitoring for women’s specific health needs.
Sponsored | Affiliate link
Affiliate disclosure: Affiliate links present. See our Affiliate Disclosure.
Ready to Start GLP-1 Treatment?
Compare our top-rated online providers — all physician-supervised, no insurance needed.
Sponsored links – we may earn a commission at no cost to you